Somatostatin analogue in the localization and treatment of bronchial carcinoid tumours.
Octreotide scanning is increasingly being used to detect tumours with somatostatin receptors. Moreover, there is growing interest in the use of somatostatin analogues for the treatment of tumours with somatostatin receptors. This review documents the use at our institution of the octreotide scan in three patients with intrathoracic pathology, and comments on overall experience in the literature with this technology.
Temeck
B K
BK
Thoracic Oncology Section, Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1502, USA.
Koong
S S
SS
Reynolds
J C
JC
Pass
H I
HI
D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D001984:Bronchial Neoplasms / Q000175:diagnosis* / Q000601:surgery; D002276:Carcinoid Tumor; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed
D018931:Antineoplastic Agents, Hormonal; D015282:Octreotide